US9422333, I-23

ID: ALA3954962

Chembl Id: CHEMBL3954962

PubChem CID: 44815162

Max Phase: Preclinical

Molecular Formula: C38H51F3N8O8

Molecular Weight: 804.87

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)NC[C@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(OC(=O)C(F)(F)F)C(=O)NC1CC1

Standard InChI:  InChI=1S/C38H51F3N8O8/c1-3-9-25(31(35(54)45-23-14-15-23)57-37(56)38(39,40)41)46-34(53)30-24-13-8-12-22(24)20-49(30)36(55)27(19-44-28(50)4-2)47-33(52)29(21-10-6-5-7-11-21)48-32(51)26-18-42-16-17-43-26/h4,16-18,21-25,27,29-31H,2-3,5-15,19-20H2,1H3,(H,44,50)(H,45,54)(H,46,53)(H,47,52)(H,48,51)/t22-,24-,25-,27-,29-,30-,31?/m0/s1

Standard InChI Key:  UABMAUQOFZTIIT-QQWMEIISSA-N

Associated Targets(non-human)

NS3 protease (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NS4A Hepatitis C virus serine protease, NS3/NS4A (1215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 804.87Molecular Weight (Monoisotopic): 804.3782AlogP: 1.61#Rotatable Bonds: 17
Polar Surface Area: 217.89Molecular Species: NEUTRALHBA: 10HBD: 5
#RO5 Violations: 1HBA (Lipinski): 16HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.84CX Basic pKa: 0.30CX LogP: 1.39CX LogD: 1.39
Aromatic Rings: 1Heavy Atoms: 57QED Weighted: 0.11Np Likeness Score: -0.23

References

1.  (2016)  HCV protease inhibitors and uses thereof, 

Source

Source(1):